ATE329268T1 - Verfahren zur bestimmung der anfangsdosis von vitamin d verbindungen - Google Patents
Verfahren zur bestimmung der anfangsdosis von vitamin d verbindungenInfo
- Publication number
- ATE329268T1 ATE329268T1 AT01981868T AT01981868T ATE329268T1 AT E329268 T1 ATE329268 T1 AT E329268T1 AT 01981868 T AT01981868 T AT 01981868T AT 01981868 T AT01981868 T AT 01981868T AT E329268 T1 ATE329268 T1 AT E329268T1
- Authority
- AT
- Austria
- Prior art keywords
- vitamin
- compounds
- determining
- initial dose
- dose
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/82—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving vitamins or their receptors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A61P5/16—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4 for decreasing, blocking or antagonising the activity of the thyroid hormones
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/50—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Organic Chemistry (AREA)
- Medical Informatics (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Pathology (AREA)
- Primary Health Care (AREA)
- Rheumatology (AREA)
- Biotechnology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Data Mining & Analysis (AREA)
- Databases & Information Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24012600P | 2000-10-13 | 2000-10-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE329268T1 true ATE329268T1 (de) | 2006-06-15 |
Family
ID=22905214
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01981868T ATE329268T1 (de) | 2000-10-13 | 2001-10-12 | Verfahren zur bestimmung der anfangsdosis von vitamin d verbindungen |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20030092686A1 (de) |
| EP (1) | EP1334367B1 (de) |
| JP (1) | JP2004532801A (de) |
| AT (1) | ATE329268T1 (de) |
| AU (2) | AU2002213483B2 (de) |
| CA (1) | CA2423316A1 (de) |
| CY (1) | CY1106146T1 (de) |
| DE (1) | DE60120458T2 (de) |
| DK (1) | DK1334367T3 (de) |
| ES (1) | ES2266276T3 (de) |
| PT (1) | PT1334367E (de) |
| WO (1) | WO2002031514A2 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100015246A1 (en) * | 2000-06-27 | 2010-01-21 | Shire International Licensing B.V. | Combination of a lanthanum compound and bone enhancing agent for the treatment of bone diseases |
| GB0015745D0 (en) * | 2000-06-27 | 2000-08-16 | Shire Holdings Ag | Treatment of bone diseases |
| US7700608B2 (en) * | 2004-08-04 | 2010-04-20 | Shire Holdings Ag | Quinazoline derivatives and their use in the treatment of thrombocythemia |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5602116A (en) * | 1988-08-02 | 1997-02-11 | Bone Care International, Inc. | Method for treating and preventing secondary hyperparathyroidism |
| US5891868A (en) * | 1997-11-21 | 1999-04-06 | Kaiser Foundation Health Plan, Inc. | Methods for treating postmenopausal women using ultra-low doses of estrogen |
| US6066091A (en) * | 1998-02-23 | 2000-05-23 | North Carolina State University | Methods, systems and products for determining drug withdrawal intervals |
-
2001
- 2001-10-12 US US09/975,853 patent/US20030092686A1/en not_active Abandoned
- 2001-10-12 DK DK01981868T patent/DK1334367T3/da active
- 2001-10-12 PT PT01981868T patent/PT1334367E/pt unknown
- 2001-10-12 EP EP01981868A patent/EP1334367B1/de not_active Expired - Lifetime
- 2001-10-12 AT AT01981868T patent/ATE329268T1/de not_active IP Right Cessation
- 2001-10-12 WO PCT/US2001/042708 patent/WO2002031514A2/en active IP Right Grant
- 2001-10-12 CA CA002423316A patent/CA2423316A1/en not_active Abandoned
- 2001-10-12 ES ES01981868T patent/ES2266276T3/es not_active Expired - Lifetime
- 2001-10-12 DE DE60120458T patent/DE60120458T2/de not_active Expired - Fee Related
- 2001-10-12 JP JP2002534848A patent/JP2004532801A/ja active Pending
- 2001-10-12 AU AU2002213483A patent/AU2002213483B2/en not_active Ceased
- 2001-10-12 AU AU1348302A patent/AU1348302A/xx active Pending
-
2006
- 2006-08-24 CY CY20061101187T patent/CY1106146T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002031514A3 (en) | 2003-06-05 |
| CY1106146T1 (el) | 2011-06-08 |
| US20030092686A1 (en) | 2003-05-15 |
| EP1334367A2 (de) | 2003-08-13 |
| PT1334367E (pt) | 2006-10-31 |
| AU1348302A (en) | 2002-04-22 |
| CA2423316A1 (en) | 2002-04-18 |
| EP1334367B1 (de) | 2006-06-07 |
| DK1334367T3 (da) | 2006-10-09 |
| DE60120458D1 (de) | 2006-07-20 |
| JP2004532801A (ja) | 2004-10-28 |
| AU2002213483B2 (en) | 2007-03-29 |
| WO2002031514A2 (en) | 2002-04-18 |
| DE60120458T2 (de) | 2007-01-11 |
| ES2266276T3 (es) | 2007-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2001027119A3 (de) | Substanzbibliothek enthaltend bicyclische imidazo-5-yl-amine und/oder bicyclische imidazo-3-yl-amine | |
| EE200000318A (et) | Uudsed ühendid | |
| ATE321048T1 (de) | Beta-amino-tetrahydroimidazo(1,2-a)pyrazine und - tetrahydrotriazolo(4,3-a)pyrazine als dipeptidyl peptidase inhibitoren zur behandlung oder prevention von diabetes | |
| ATE250932T1 (de) | Verfahren zur behandlung von chronischem schmerz durch verabreichung von einem mek hemmer | |
| ATE339406T1 (de) | Chinazoline verbindungen als heilmittel | |
| DE69832209D1 (de) | Verfahren zur Herstellung von 3,3-Dimethylbutyraldehyd durch Oxidation von 3,3-Dimethylbutanol | |
| TR200302214T4 (tr) | Psoriasis tedavisi için kullanilan pteridine bileşkenleri | |
| ATE521357T1 (de) | Verfahren zur behandlung von hepatitis | |
| ATE502648T1 (de) | Verfahren zur behandlung von autoimmunerkrankungen bei einem probanden und diagnostische in-vitro-assays | |
| DE10197144T1 (de) | Verfahren zur Herstellung von Nitrilverbindungen aus ethylenisch ungesättigten Verbindungen | |
| DE69802918D1 (de) | Vwf propeptide enthaltendes pharmazeutisches präparat | |
| ES2160410T3 (es) | Preparados de complejos de protrombina inmunotolerantes. | |
| DE60218843D1 (de) | Verfahren zur identifizierung von mitteln zur behandlung von diabetes | |
| ATE268749T1 (de) | Verfahren zur herstellung von iopamidol | |
| ATE238315T1 (de) | Verfahren zur herstellung von dinatriumpamidronat | |
| DE59600209D1 (de) | Verfahren zur Herstellung von 4,6-Dichlorpyrimidinen | |
| CY1105142T1 (el) | Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων | |
| DE60120458D1 (de) | Verfahren zur bestimmung der anfangsdosis von vitamin d verbindungen | |
| DK0752991T3 (da) | Indeno[1,2-e]pyrazin-4-oner, fremstilling af disse forbindelser og lægemidler indeholdende disse forbindelser | |
| DE69824839D1 (de) | Verfahren zur herstellung von 2-aryl-3-aryl-5-halogen-pyridinen, verwendbar als cox-2 inhibitoren | |
| ATE111734T1 (de) | Verfahren zur herstellung von direktkomprimierten, cephalosporansäure derivate enthaltendentabletten. | |
| NZ519722A (en) | Treatment of diabetic ulcers | |
| IS1801B (is) | Pýridýlbisfosfónöt til notkunar sem efni til lækninga | |
| DK0614366T3 (da) | Anvendelse af creatinphosphat eller phosphoenolpyrodruesyre til behandling af tumorer | |
| DE69820580D1 (de) | Verfahren zur Abtrennung von Metallen durch micellare Ultrafiltration, geeignet zur Behandlung von radioaktiven Abfallstoffen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1334367 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |